President Donald Trump on Friday plans to outline a series of initiatives aimed at curbing drug prices, unveiling a blueprint to drive down costs amid complaints that Washington has done little to address the issue. The speech, which has been twice delayed, is spurring skepticism from industry experts and Democrats who say it won’t make a serious dent in costs. They say the proposals fall short of Mr. Trump’s pledge to go after pharmaceutical companies he said last year were “getting away with murder.”...

Source: Wall Street Journal May 10, 2018 09:33 UTC